chrisvoncsefalvay/vaers-outcomes huggingface dataset:
lightheadedness; dizziness; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (lightheadedness) and DIZZINESS (dizziness) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced DIZZINESS (lightheadedness) and DIZZINESS (dizziness). At the time of the report, DIZZINESS (lightheadedness) and DIZZINESS (dizziness) outcome was unknown.            no concomitant medications are provided. treatment to the events not reported.  Action taken with mRNA-1273 in response to the event was not applicable. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
Extreme arm and shoulder pain and great difficulty moving arm and shoulder.  Onset of pain and difficulty in use was within hours of vaccine administration and worsened over the next three days.  The pain was significant enough to require use of pain relieving medications throughout the day and night.  The pain woke me up at night.  Unable to lift arm more than a few inches for several days.  Difficulty moving arm, arm felt very heavy, so much so that if I was rolling over in bed I couldn't move my arm and needed to use the hand of  my other arm to do so.  Unable to lift arm to the back of my head (for example to put an elastic in my hair) for a week.  A high degree of pain for about 5 days, reducing somewhat after that and lasted about 2 weeks.  Still, nearly 4 weeks later, my arm is sore when I move it at the very top into the shoulder.  It's difficult to hook my bra.  I am not in pain but often have little twinges of pain/discomfort in the upper arm/shoulder, particularly when I lift my arm upward from the side of my body.
This spontaneous report was received from a pharmacist via Poison And Drug Center referring to a male patient of unknown age. There was no information about patient's medical history, concurrent conditions and concomitant medications. On an unknown date, the patient started vaccination with M-M-R II (lot #, expiration date, frequency, route and dose unknown) for prophylaxis. On 11-MAR-2017 at 11: 00, the patient received M-M-R II (lot # M039914, expiration date: 26-SEP-2018) subcutaneously because he needed a booster. Around 16:00, he texted the pharmacist to let her know that his arm turned purplish and black. The pharmacist thought that it was a bruise (Contusion). It was unknown if there was relevant lab work. As of 11-MAR-2017, it was unknown if the patient would continue with M-M-R II and had not recovered from the event. The causality between the event and M-M-R II was not provided. Additional information has been requested.
Site: Pain at Injection Site-Mild, Systemic: Chest Tightness / Heaviness / Pain-Severe, Systemic: sharp chest pain and shortness of breath. on and off since 1st dose-Severe, Systemic: Flushed / Sweating-Mild, Systemic: Hypotension-Medium, Additional Details: She states that some of her chest pain is sharp and causes shortness of breath. She had to take a break at work and sit for 30 minutes. She is going to have appointment with PCP to check it out before her 2nd dose.
vaccine adm @ 12:35 pm 5/18/2021 ,first event occurred 12:37 pm (passed out/muscle weakness(slumping)/ when over has no memory of event total time 5-7 seconds, then  alert  some sweating. second event same as first occurred 5 minutes later( was given water after first event.) CALLED 911 ARRIVED 5-10 MINUTES AFTER SECOND EVENT. after exam bp/blood glucose/pules/O2 sat/all normal(per emt) patient walked out under own power
Red, Warm to the touch, itchy rash. All at injection site. Patient also complained of headache.
Onset w/ fever, napped, woke w/ jerking -all extremities - & seemed to stop breathing, vomited X1.  No sxs 7-10-90.  Given APAP q4h on 7-11-90.
RAPID HEARTBEAT SYMPTOMS; This spontaneous report received from a patient concerned a male of unspecified age. The patient's height, and weight were not reported. The patient's past medical history included rapid heartbeat symptoms, and covid-19.  The patient received covid-19 vaccine  (suspension for injection, route of admin, and batch number were not reported) dose was not reported, administered on 20-MAY-2021 15:00 for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. On MAY-2021, the subject experienced rapid heartbeat symptoms. The action taken with covid-19 vaccine  was not applicable. The outcome of rapid heartbeat symptoms was not reported. This report was non-serious.
2 DAYS AFTER ADMINISTRATION OF ANTHRAX. PT HAD AN ONSET OF A RASH. PT WENT TO MEDICAL CENTER. RASH WAS FINE MACULAR W/ POSITIVE BLANCHING TO TORSO, NECK, AND FACE. POSITIVE PRURITIC. PT WAS TREATED W/ PREDNISONE 40 MG DAILY X 4 DAYS, ZANTAC 150  BID X 10-14 DAYS, GIVEN BENADRYL 25 PRN, SIQ X 24HRS
The first time the HIB was administered, he slept for over 12 hours.  (The second time the HIB was administered, he slept, with no food or water intake for over 20 hours).  Sleeping did not occur with any of the other immunizations.
pt recv vax AUG & SEP95 w/no rxn;21APR96 pt devel flu-like sx consisting of h/a, muscle aches, pain & t99.8;24APR96 devel rash which began as papule & went on to form vesicles on erythematous base;100 itchy lesion;breakthrough chicken pox
On 7/30/22, patient  was running  in his neighborhood and had an unwitnessed cardiac arrest. Bystander called EMS & police. ACLS / CPR performed by EMS and within 4 minutes patient had pulse. Intubated and brought to the hospital. Admitted to intensive care unit intubated on ventilator.  On 8/2/22 at 1620 patient was pronounced dead.  (Patient had been on high school track team and ran daily.  Toxicology report - negative).
COVID VACCINE CLINIC  12/18/2020    Subjective Patient is a 32 y.o. female who was seen at the COVID Vaccine Clinic today for her first dose of the COVID 19 vaccination.    She denied any history of previous adverse reactions to vaccines.   She was given the Pfizer vaccination in the right deltoid muscle.   During her 15 minute waiting period after the injection, the patient began to experience dizziness.  Also c/o tingling in hands and feet. She denied rash, hives, difficulty breathing, difficulty swallowing, wheezing, throat tightness, hoarseness, itching and tongue swelling.   This provider was notified of patient reaction and she was then assessed in the emergency bay area.   Review of Systems     Objective   Visit Vitals BP 111/78 Pulse 76 SpO2 100%       Physical Exam HENT:     Head: Normocephalic.     Right Ear: Tympanic membrane normal.     Left Ear: Tympanic membrane normal.     Nose: Nose normal.  Neck:     Musculoskeletal: Normal range of motion.  Cardiovascular:     Rate and Rhythm: Normal rate.  Pulmonary:     Effort: Pulmonary effort is normal.  Musculoskeletal: Normal range of motion.  Skin:    General: Skin is warm.     Capillary Refill: Capillary refill takes less than 2 seconds.  Neurological:     Mental Status: She is alert.  Psychiatric:        Mood and Affect: Mood normal.        Assessment/Plan    Treatment included water, granola bar, and rest. Follow up response to treatment:excellent Patient discharge:  Stable to go home and follow up with PCP   Watch for signs for allergic reaction danger signs:
Information has been received from a registered nurse via a company representative referring to an 18 year old male patient. The patient's concurrent condition and medical history were not reported. On 13-AUG-2015 the patient was vaccinated with a dose of GARDASIL (lot#, expiration date, dose and route were unknown) (it was not reported which dose in the vaccine series he was given). On 13-AUG-2015, the patient experienced syncope after receiving therapy with GARDASIL. The patient sought medical attention by office visit. The patient was given water, instructed to elevate his feet and lay down for 15 minutes. The outcome of syncope was reported as recovering/resolving. Additional information is not expected as the reporter asked not to be contacted.
This spontaneous report was received from other health professional and refers to a 1 year old male patient. The patient's concomitant therapies included M-M-R II, hepatitis A virus vaccine (unspecified) and PREVNAR 13. The patient had no known drug allergies (NKDA). On 03-APR-2017 15:15 hrs, the patient was vaccinated with improperly stored VARIVAX (lot # M028553, expiration date: 07-JUN-2018) dose 1, subcutaneously in the left thigh for prophylaxis. No adverse effects were reported. The doses of VARIVAX were stored in the temperatures from 15 Fahrenheit degrees (F) to 46 F (23.2 F) for 96 hours (dates were not reported). There were no previous temperature excursions. The digital data logger was not involved. No Product Quality Complaint (PQC) was involved. This case is cross-referenced with 1704USA006422, 1706USA000221, 1706USA000261 and 1706USA001751 (Same reporter link). Additional information has been requested. Sender's Comments: US-009507513-1704USA006422: US-009507513-1706USA000221: US-009507513-1706USA000261: US-009507513-1706USA001751.
Pt recv vax on 1/7/99; on 1/12/99 pt exp  sand paper-like rash on right & left forearms & hands
did feel terrible; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 46 year-old female patient received bnt162b2 (BNT162B2), intramuscular, administered in arm left, administration date 04Mar2021 16:00 (Lot number: EN6198) at the age of 46 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "Hypothyroid" (ongoing). Concomitant medication(s) included: SYNTHROID taken for hypothyroidism (ongoing). Vaccination history included: Bnt162b2 (Dose: 1st, Time (24 hr): 4:50 pm, Site and Route of injection: Left Arm, Route of administration: intramuscular, Batch/Lot number: EN6201), administration date: 13Feb2021, when the patient was 46 years old, for COVID-19 immunization, reaction(s): "Dizzy last night", "Raised bumps on torso from neck to butt/when run finger over them they stung/hot tub rash", "hot tub rash". The following information was reported: FEELING ABNORMAL (non-serious) with onset Mar2021, outcome "recovered" (Mar2021), described as "did feel terrible".  Additional information: Patient has no allergies to medications, food, or other products. Prior to vaccination, the patient was not diagnosed with COVID-19; and since the vaccination, has not been tested for COVID-19.  The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. It was reported that after the second vaccine, patient did feel terrible for 2 days but it was manageable.  No follow-up attempts are possible. No further information is expected.
Red hot welt at vaccine site-immediately  About 30 min after receiving the first vaccine I started to get hives all over my chest, back, and both arms. I took Benadryl every 4-6 hours for 3 days until the hives subsided.  Extreme headaches for 3 days.  Dizziness x 6 days.
Transient low blood pressure with few minutes of vaccine administration. Nothing to suggest allergy. Resolved after about 15 minutes.
Moderna COVID-19 Vaccine EUA swollen axillary lymph nodes of left arm (arm of injection)
got covid/ lost our sense of taste and smell/ cough; got covid/ lost our sense of taste and smell/ cough; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A male patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) for 1 day as dose 1, single and (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 17Oct2021, outcome "unknown" and all described as "got covid/ lost our sense of taste and smell/ cough". The patient underwent the following laboratory tests and procedures: sars-cov-2 test: (18Oct2021) positive. Clinical course: After having 2 vaccines, patient got Covid. On 18Oct, he got tested and on 19Oct2021, he tested positive. His symptoms were bad including a cough. The lot number for bnt162b2 was not provided and will be requested during follow up.
Triggered Chron?s symptoms for 2 weeks - stomach aches and diarrhea abs then I got shingles in May
I was having some COVID-19 symptoms during drive back from traveling and when we got home on the 19th I used a home test and it was positive. I was fatigued, had a runny nose and coughing. Three days later I tested again and it was positive still. By the 29th my symptoms other than congestion in my chest were pretty much gone I took another test and then contacted my doctor since I was still positive. On the 2nd of July I spoke with a COVID unit and they advised I keep testing until I was negative and then to do a second test within 48 hours of the first negative test. My doctor also sent me for an X-ray to make sure my lungs were doing okay.
My right leg has been very tight with a small bump between knee cap & ankle. Shortly after the second dose. ON 3/26/2021.
Excessive crying, inconsolable greater than 5 hours.  Started night of date of injection.
Headaches, Nausea, Body Aches, Fatigue all only on  day after vaccination.  Loss of Taste still present on day 4.
Tightness of chest - nauseous - flu-like symptoms - no fever - body aches - lasted from 9/25/10 to 9/30/10.
Anaphylaxis; Difficulty breathing; Shortness of breath; Swollen lips, tongue, eyes, or face.
On 10/20/2021 fatigue, sinus issues, low grade fever, cough, and congestion in chest. Still on going on.  On a video call doctor gave me Prednisone, antibiotic, and Albuterol in haler. Treated as a breakthrough infection.
patient didn´t received Shingrix 2nd dose after one year since 1st dose; This case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (1st dose received in 2020, 1 year prior to reporting date).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional details were reported as follows: The age at vaccination was not applicable for this report. Till the time of reporting, the patient did not receive 2nd dose of Shingrix after one year since 1st dose administration, which led to incomplete course of vaccination.
Systemic: Allergic: Difficulty Breathing-Severe, Systemic: Fainting / Unresponsive-Severe, Systemic: Seizure-Severe, Systemic: Shakiness-Severe
huge red rash the size of a baseball; This spontaneous case was reported by a consumer and describes the occurrence of RASH ERYTHEMATOUS (huge red rash the size of a baseball) in a 63-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 021b21a) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Apr-2021, the patient experienced RASH ERYTHEMATOUS (huge red rash the size of a baseball). At the time of the report, RASH ERYTHEMATOUS (huge red rash the size of a baseball) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       This case was linked to MOD-2021-097697.   Most recent FOLLOW-UP information incorporated above includes: On 29-Apr-2021: Follow-up received contains no new information.
I woke on 3/26/22 with my right side of my face collapsed I went to the doctor and was diagnosed with bells palsy. I was prescribed with prednisone. I went to a neurologist who confirmed the diagnosis and ran some tests. My PCP agreed with the diagnosis.
patient still get the flu; Initial information was received on 11-Dec-2020 regarding an unsolicited valid non-serious case from a social media via consumer or non-health care professional (patient).  This case involves patient [age and gender unspecified] who still get the flu (influenza), while patient received vaccine INFLUENZA VACCINE [Flu shot].  Medical history, medical treatment, vaccination, concomitant medication and family history were not provided.  On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE (produced by unknown manufacturer) [lot number and expiry date not reported] via an unknown route at an unknown administration site for prophylactic vaccination.  On an unknown date, the patient still get the flu (influenza) (non-serious) unknown latency following the administration of INFLUENZA VACCINE.  Details of laboratory data not reported.  It was not reported if the patient received any corrective treatment.  At the time of reporting, the event outcome reported as unknown for event.  There will be no information available on the batch number for this case.
Patient reports illness started with swollen painful neck lymph nodes. On exam + painful anterior cervical lymphadenopathy. Patient states she developed dizzy spells with tunnel vision, headache and fever yesterday with max temp 102F, which has since resolved. Patient felt like she was going to faint. Patient reports she's had associated body aches and fatigue.
Described, by patient, as chills, sore throat, nausea and vomiting.  Redness and swelling 30X20 mm at site of injection, right upper arm.
"debilitating reaction." / described it as "weakness or tiredness"; "debilitating reaction." / described it as "weakness or tiredness" / Fatigue problems.; she has Anemia; had / the Zostavax vaccine in 09/25/2007 / got / 1st Shingrix / on November 12th, 2019 / 2nd dose on June 18th, 2020.; This case was reported by a consumer via call center representative and described the occurrence of weakness in a 77-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Zostavax vaccine with an associated reaction of no adverse event (received on 25th September 2007 and did not had reaction to this live vaccine) and Shingrix with an associated reaction of asthenia (received 1st dose on 12th November 2019, refer case US2021047828).   On 18th June 2020, the patient received the 2nd dose of Shingrix. On 18th June 2020, unknown after receiving Shingrix, the patient experienced drug dose administration interval too long. On an unknown date, the patient experienced weakness, fatigue and anemia. On an unknown date, the outcome of the weakness, fatigue, anemia and drug dose administration interval too long were unknown.   It was unknown if the reporter considered the weakness, fatigue and anemia to be related to Shingrix.  Additional details were provided as follows: The patient had medical conditions that were not present when had the vaccines. At the time of reporting the patient take Thyroid medications and not received it when she took the Shingrix Vaccines. The patient received Shinrgix in left arm and had weakness or tiredness. The patient reported anemia and fatigue problems after taking vaccine. The reporter consented to follow up and did not find the lot and expiration dates of the vaccines.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021047828:same reporter
Day 1-5 after injection fatigue, Day 2 enhanced sense of taste and smell, Day 4 red flat rash on torso
Possible vaccine failure. Patient developed invasive bacteremia (streptococcus pneumoniae). Patient has a history of hypogammaglobulemia.  Nurse follow up for 06/25/04 states: "No new information."  Nurse follow up on 08/26/04 states: "swelling (L) cheek; fever."
Puffy eyes, no rash but skin red and felt itchy all over. Pt said "doesn't feel well". No fever. No irritation at injection site. No difficulty breathing, swelling of lips, tongue or throat. Took BENADRYL at 8:30 am on 12/17/20016. That helped. Called back 12/17/2016 and 5pm on 12/18/2016. Pt stated feeling better and not itching as much. Has not taken any more BENADRYL.
He is currently hopsitalized for lack of blood flow to 2 of  his fingertips.   It started with his right ring finger tuned white and extremely painful, then turned purple..  Then over the next week or 2 it started in pinky finger.  The ring finger is now numb at times, and sometimes it tingles.   The pinky finger is still  very painful.  He is hospitalized for this condition as they are performing tests to try to figure out the cause.   The hospital isnt saying its the vaccine, but we just wanted to let you know about his symptoms. In case it does have something to do with the vaccine.
During the last week of February the patient states she was feeling off and having intermittent episodes of dizziness.   On the day of admission she had an episode of wording finding difficulty that lasted for approximately 15 minutes.  By the time she presented to the ED her symptoms had resolved.  Patient had been diagnosed with DVT and PE in October 2020.  She had been warfarin for many years for history of DVT.  Her INRs had recently been fluctuating considerably and so she was changed to Eliquis.  A few weeks before her admission there was concern that her that the Eliquis wasn't working because a lower extremity ultrasound showed persistent DVT so she was converted to Lovenox..  Patient was admitted to the hospital.  After her work-up she was discharged with a diagnosis of TIA.  Cardiologist requested that event be submitted to VAERS.
Dose 1: Sore left arm the next morning for 24 hours then gone. Dose 2: Sore right arm early next morning, slight headache then headache gone post Tylenol administration.
Meningitis dx one month p/giving MMR/DTP/OPV (bacterial?);
Patient was inadvertently administered a Pfizer vaccine 8 days after receiving a Moderna vaccine at another provider. The patient contacted the clinic one week later and stated that she had been feeling ill since receiving the second vaccine. She reported that she had been having fevers and general malaise.